Éric Dailly

3.6k total citations · 1 hit paper
91 papers, 2.4k citations indexed

About

Éric Dailly is a scholar working on Infectious Diseases, Pharmacology and Virology. According to data from OpenAlex, Éric Dailly has authored 91 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 30 papers in Pharmacology and 19 papers in Virology. Recurrent topics in Éric Dailly's work include HIV/AIDS drug development and treatment (22 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and HIV Research and Treatment (19 papers). Éric Dailly is often cited by papers focused on HIV/AIDS drug development and treatment (22 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and HIV Research and Treatment (19 papers). Éric Dailly collaborates with scholars based in France, Canada and United States. Éric Dailly's co-authors include Michel Bourin, Pascale Jolliet, Caroline Renard, Martine Hascoët, Franck Chenu, Guillaume Deslandes, François Raffi, Denis J. David, Nadège Ripoll and Matthieu Grégoire and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Éric Dailly

88 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)

2019 335 citations Éric Dailly, Claire Roger et al. profile →

Peers

Countries citing papers authored by Éric Dailly

Since Specialization

Citations

This map shows the geographic impact of Éric Dailly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Dailly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Dailly more than expected).

Fields of papers citing papers by Éric Dailly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Dailly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Dailly. The network helps show where Éric Dailly may publish in the future.

Co-authorship network of co-authors of Éric Dailly

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Dailly. A scholar is included among the top collaborators of Éric Dailly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Dailly. Éric Dailly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	N-acetylcysteine use in a cocaine-induced liver failure: a case report 2025 ·Frontiers in Toxicology ·(unknown), Ronan Bellouard, (unknown), Éric Dailly, (unknown), (unknown)	1
2	Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis 2023 ·Journal of Antimicrobial Chemotherapy ·Ronan Bellouard, (unknown), (unknown), Éric Dailly, R. Lecomte, Colin Deschanvres, Anne‐Gaëlle Leroy, David Boutoille, Paul Le Turnier, Matthieu Grégoire, (unknown), Benjamin Gaborit, (unknown), Guillaume Deslandes, (unknown), Stéphane Corvec, Florent Morio, Jean‐François Huon, Dominique Navas	3
3	Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach 2023 ·Antibiotics ·(unknown), Ronan Bellouard, Guillaume Deslandes, (unknown), Claire Roger, Séverine Ansart, Éric Dailly, Cédric Bretonnière, Matthieu Grégoire	2
4	A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections—a monocentre quality improvement project 2023 ·Journal of Antimicrobial Chemotherapy ·(unknown), Marwan Bouras, Ronan Le Floch, Yannick Hourmant, Nicolas Grillot, (unknown), Pierre Mahé, Dominique Demeure Dit Latte, Matthieu Grégoire, Éric Dailly, Ronan Bellouard, Karim Asehnoune, Raphaël Cinotti, Antoine Roquilly	3
5	Pharmacokinetics and toxicity of high-dose baclofen in ICU patients 2019 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Mickaël Vourc’h, Éric Dailly, Yannick Hourmant, Ronan Bellouard, Pierre-Joachim Mahé, Guillaume Deslandes, Matthieu Grégoire, Karim Asehnoune	7
6	Prophylactic cefazolin concentrations in morbidly obese patients undergoing sleeve gastrectomy: do we achieve targets? 2018 ·International Journal of Antimicrobial Agents ·Matthieu Grégoire, Romain Dumont, (unknown), Jean‐Baptiste Woillard, (unknown), E Letessier, Raphaël Cinotti, Antoine Roquilly, Guillaume Deslandes, Pascale Jolliet, Karim Asehnoune, Éric Dailly	11
7	Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications 2017 ·Alimentary Pharmacology & Therapeutics ·Quentin Le Bastard, Gabriel A. Al‐Ghalith, Matthieu Grégoire, Guillaume Chapelet, François Javaudin, Éric Dailly, Éric Batard, Dan Knights, Emmanuel Montassier	156
8	Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay 2016 ·American Journal of Clinical Pathology ·Régis Bouquié, Matthieu Grégoire, (unknown), (unknown), Éric Dailly, (unknown), Alain Pineau, Guillaume Deslandes, Pascale Jolliet	23
9	Influence of nevirapine administration on the pharmacokinetics of dolutegravir in patients infected with HIV-1 2015 ·Journal of Antimicrobial Chemotherapy ·Éric Dailly, Clotilde Allavena, Matthieu Grégoire, Véronique Reliquet, Régis Bouquié, Éric Billaud, (unknown), Sabelline Bouchez, Guillaume Deslandes, Nolwenn Hall, Pascale Jolliet, François Raffi	6
10	A liquid chromatography–tandem mass spectrometry assay for quantification of rilpivirine and dolutegravir in human plasma 2014 ·Journal of Chromatography B ·Matthieu Grégoire, Guillaume Deslandes, Christian Renaud, Régis Bouquié, Clotilde Allavena, François Raffi, Pascale Jolliet, Éric Dailly	25
11	Chiral on-line solid phase extraction coupled to liquid chromatography–tandem mass spectrometry assay for quantification of (R) and (S) enantiomers of methadone and its main metabolite in plasma 2014 ·Talanta ·Régis Bouquié, (unknown), Guillaume Deslandes, (unknown), (unknown), Marie Grall‐Bronnec, Éric Dailly, Pascale Jolliet	13
12	Pharmacokinetics of ertapenem in burns patients 2013 ·International Journal of Antimicrobial Agents ·Éric Dailly, (unknown), (unknown), (unknown), (unknown), Régis Bouquié, Guillaume Deslandes, Pascale Jolliet, R. Le Floch	13
13	Effect of Efavirenz, Nevirapine, Etravirine, and Raltegravir Administration on the Pharmacokinetics of Ritonavir-Boosted Darunavir in a Population of HIV-Infected Patients 2012 ·AIDS Research and Human Retroviruses ·Éric Dailly, Clotilde Allavena, Régis Bouquié, Guillaume Deslandes, François Raffi, Pascale Jolliet	1
14	Impact of nevirapine or efavirenz co‐administration on ritonavir‐boosted amprenavir pharmacokinetics in HIV‐infected patients 2008 ·Fundamental and Clinical Pharmacology ·Éric Dailly, François Raffi, Charlotte Biron, Clotilde Allavena, Pascale Jolliet	2
15	Preclinical and Clinical Pharmacology of Cyamemazine: Anxiolytic Effects and Prevention of Alcohol and Benzodiazepine Withdrawal Syndrome 2004 ·CNS Drug Reviews ·Michel Bourin, Éric Dailly, Martine Hascoët	26
16	Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection 2004 ·Journal of Chromatography B ·Éric Dailly, François Raffi, Pascale Jolliet	67
17	No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors 2004 ·European Journal of Clinical Pharmacology ·Éric Dailly, Éric Billaud, (unknown), (unknown), (unknown), (unknown), Pascale Jolliet, Michel Bourin, (unknown)	28
18	Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test 2003 ·Fundamental and Clinical Pharmacology ·Caroline Renard, Éric Dailly, Denis J. David, Martine Hascoët, Michel Bourin	127
19	Antidepressant-like effects in various mice strains in the tail suspension test 2003 ·Behavioural Brain Research ·Nadège Ripoll, Denis J. David, Éric Dailly, Martine Hascoët, Michel Bourin	145
20	pH Dependent Binding of Ligands to Serum Lipoproteins 1997 ·Pharmaceutical Research ·Nicolas Simon, Éric Dailly, Pascale Jolliet, Jean‐Paul Tillement, Saı̈k Urien	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact